Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants
Public ClinicalTrials.gov record NCT04484857. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3b Multicenter, Open-Label Single Arm Study of Roxadustat: Either as Conversion From an Erythropoiesis Stimulating Agent (ESA), or as Initial Anemia Treatment in Hemodialysis (HD) Patients
Study identification
- NCT ID
- NCT04484857
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Kyntra Bio
- Industry
- Enrollment
- 283 participants
Conditions and interventions
Interventions
- Roxadustat Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2020
- Primary completion
- Jul 8, 2021
- Completion
- Sep 16, 2021
- Last update posted
- Jul 25, 2022
2020 – 2021
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska | Anchorage | Alaska | 99515 | — |
| Investigator Site | Pine Bluff | Arkansas | 71603 | — |
| Investigational Site | Cerritos | California | 90703 | — |
| Investigational Site | Victorville | California | 92394 | — |
| Investigational Site | Denver | Colorado | 80230 | — |
| Investigational Site | Hartford | Connecticut | 06112 | — |
| Investigational Site | Coral Gables | Florida | 33134 | — |
| Investigational Site | Hollywood | Florida | 33024 | — |
| Investigator Site | Dalton | Georgia | 30720 | — |
| Investigational Site | Statesboro | Georgia | 30458 | — |
| Investigational Site | Roseville | Michigan | 48066 | — |
| Investigational Site | Kansas City | Missouri | 64111 | — |
| Investigational Site | Las Vegas | Nevada | 89178 | — |
| Investigator Site | Gallup | New Mexico | 87301 | — |
| Investigational Site | The Bronx | New York | 10461 | — |
| Investigational Site | Austin | Texas | 78229 | — |
| Investigator Site | Dallas | Texas | 75237 | — |
| Investigational Site | El Paso | Texas | 79924 | — |
| Investigational Site | Houston | Texas | 77004 | — |
| Investigator Site | San Antonio | Texas | 78202 | — |
| Investigator Site | San Antonio | Texas | 78211 | — |
| Investigator Site | San Antonio | Texas | 78221 | — |
| Investigational Site | San Antonio | Texas | 78229 | — |
| Investigational Site | San Antonio | Texas | 78251 | — |
| Investigator Sites | San Antonio | Texas | 78521 | — |
| Investigational Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04484857, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 25, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04484857 live on ClinicalTrials.gov.